Related Experiment Video

Updated: May 28, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Compensatory and non-compensatory effects on protein expression following BCL-2 suppression by antisense

Marvin Rubenstein1, Courtney M P Hollowell, Patrick Guinan

  • 1Division of Cellular Biology, Hektoen Institute for Medical Research, 2240 West Ogden Avenue, 2nd Floor, Chicago, IL 60612, USA. DrMarv@Prodigy.net

Medical Oncology (Northwood, London, England)
|November 1, 2011
PubMed

Insights

Antisense oligonucleotides targeting bcl-2 in prostate cancer cells led to increased androgen receptor sensitivity. Cells adapted by upregulating androgen receptor and p300, but not IL-4 or IGF1, suggesting specific compensatory pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Antisense oligonucleotides (oligos) are investigated for prostate cancer therapy, targeting growth regulatory proteins.
  • bcl-2, an apoptosis inhibitory protein, is a key target for gene therapy in prostate cancer models.

Purpose of the Study:

  • To evaluate the effects of monospecific and bispecific antisense oligos targeting bcl-2 expression in LNCaP prostate cancer cells.
  • To investigate cellular adaptation mechanisms, including changes in apoptosis-related proteins, androgen receptor (AR), and coactivators, following bcl-2 suppression.

Main Methods:

  • Utilized antisense oligonucleotides (oligos) to suppress bcl-2 expression in LNCaP cells.
  • Assessed changes in caspase-3 activity, androgen receptor (AR), p300, insulin-like growth factor 1 (IGF1), and IL-4 expression.

Main Results:

  • Suppression of bcl-2 led to decreased caspase-3 activity and increased expression of androgen receptor (AR) and p300.
  • IGF1 expression remained unchanged, indicating it is not a significant compensatory pathway.
  • IL-4, an AR coactivator, was not upregulated, suggesting it does not contribute to increased androgen sensitivity.

Conclusions:

  • bcl-2 suppression in prostate cancer cells induces adaptive changes, including increased androgen sensitivity.
  • Cellular compensation involves upregulation of AR and p300, but not IGF1 or IL-4 pathways.
  • Findings provide insights into resistance mechanisms and potential therapeutic strategies for prostate cancer gene therapy.

More Related Videos

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling10:00

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling

Published on: October 28, 2014

Related Concept Videos

What is Gene Expression?01:36

What is Gene Expression?

A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then processed and...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Dosage Compensation02:50

Dosage Compensation

In animals, gender is determined by the number and type of sex chromosome. For example, human females have two X chromosomes, and males have one X and one Y chromosome, whereas C.elegans with one X chromosome is a male, and the one with two X chromosomes is a hermaphrodite.
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with  distinct numbers of X chromosomes will have...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...